Published in Lancet on September 10, 1994
Relationship of the 37,000- and 40,000-M(r) tryptic fragments of islet antigens in insulin-dependent diabetes to the protein tyrosine phosphatase-like molecule IA-2 (ICA512). J Clin Invest (1995) 1.60
The 37/40-kilodalton autoantigen in insulin-dependent diabetes mellitus is the putative tyrosine phosphatase IA-2. Proc Natl Acad Sci U S A (1995) 0.96
Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity. Lancet (1983) 5.64
Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet (1974) 5.59
Self-monitoring of blood-glucose. Improvement of diabetic control. Lancet (1978) 5.03
In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. N Engl J Med (1985) 4.65
Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes. Diabetologia (2003) 4.33
PADGEM protein: a receptor that mediates the interaction of activated platelets with neutrophils and monocytes. Cell (1989) 3.95
Aberrant expression of HLA-DR antigen on thyrocytes in Graves' disease: relevance for autoimmunity. Lancet (1983) 3.85
Type 1 (insulin-dependent) diabetes and a highly variable locus close to the insulin gene on chromosome 11. Diabetologia (1985) 3.65
The British Diabetic Association Cohort Study, II: cause-specific mortality in patients with insulin-treated diabetes mellitus. Diabet Med (1999) 3.26
A genomewide scan for loci predisposing to type 2 diabetes in a U.K. population (the Diabetes UK Warren 2 Repository): analysis of 573 pedigrees provides independent replication of a susceptibility locus on chromosome 1q. Am J Hum Genet (2001) 3.26
Interferon-gamma induces HLA-DR expression by thyroid epithelium. Clin Exp Immunol (1985) 3.18
Epithelial cells expressing aberrant MHC class II determinants can present antigen to cloned human T cells. Nature (1985) 3.11
Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: the 2-year analysis of the German BABYDIAB Study. Diabetes (1999) 3.00
HLA class II induction in human islet cells by interferon-gamma plus tumour necrosis factor or lymphotoxin. Nature (1987) 2.96
European Nicotinamide Diabetes Intervention Trial (ENDIT): a randomised controlled trial of intervention before the onset of type 1 diabetes. Lancet (2004) 2.90
DNA polymorphic haplotypes on the short arm of chromosome 11 and the inheritance of type I diabetes mellitus. J Med Genet (1986) 2.86
Trends in childhood type 1 diabetes incidence in Europe during 1989-2008: evidence of non-uniformity over time in rates of increase. Diabetologia (2012) 2.85
Novel organ-specific circulating cardiac autoantibodies in dilated cardiomyopathy. J Am Coll Cardiol (1990) 2.67
Prediction of IDDM in the general population: strategies based on combinations of autoantibody markers. Diabetes (1997) 2.65
The selection of control subjects for case/control analysis of susceptibility to type 1 (insulin-dependent) diabetes mellitus. Diabetologia (1993) 2.63
Diabetes Antibody Standardization Program: evaluation of assays for autoantibodies to glutamic acid decarboxylase and islet antigen-2. Diabetologia (2008) 2.51
Evidence for a long prediabetic period in type I (insulin-dependent) diabetes mellitus. Lancet (1982) 2.43
Unrecognised nocturnal hypoglycaemia in insulin-treated diabetics. Lancet (1979) 2.42
Aberrant expression of HLA-DR antigens on bileduct epithelium in primary biliary cirrhosis: relevance to pathogenesis. Lancet (1984) 2.38
Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop. Diabetes (1998) 2.38
The British Diabetic Association Cohort Study, I: all-cause mortality in patients with insulin-treated diabetes mellitus. Diabet Med (1999) 2.31
Human T-cell clones from autoimmune thyroid glands: specific recognition of autologous thyroid cells. Science (1985) 2.27
Children with type-1 diabetes and their unaffected siblings have fewer symptoms of asthma. Lancet (1999) 2.26
Induction of specific storage organelles by von Willebrand factor propolypeptide. Cell (1991) 2.09
Classification of smooth muscle autoantibodies detected by immunofluorescence. J Clin Pathol (1976) 2.08
Genetic and immunologic factors in microvascular disease in type I insulin-dependent diabetes. Diabetes (1982) 2.05
Should surgeons treat diabetes in severely obese people? Lancet (2001) 2.05
Similar low frequency of anti-MOG IgG and IgM in MS patients and healthy subjects. Neurology (2004) 2.04
Presence of the organ-specific 'microsomal' autoantigen on the surface of human thyroid cells in culture: its involvement in complement-mediated cytotoxicity. Clin Exp Immunol (1981) 2.04
No risk of diabetes after insulin-shock treatment. Lancet (1992) 2.02
Incidence of childhood-onset insulin-dependent diabetes mellitus: the EURODIAB ACE Study. Lancet (1992) 2.00
Autoantibodies to zinc transporter 8 and SLC30A8 genotype stratify type 1 diabetes risk. Diabetologia (2009) 2.00
Complement-fixing islet-cell antibodies in type-I diabetes: possible monitors of active beta-cell damage. Lancet (1980) 2.00
Autoantibodies to a 128-kd synaptic protein in three women with the stiff-man syndrome and breast cancer. N Engl J Med (1993) 1.95
Rising incidence of IDDM in Europe. Diabetes Care (1989) 1.94
Autoantibodies to prolactin-secreting cells of human pituitary. Lancet (1975) 1.92
Insulin-induced hypoglycaemia in an accident and emergency department: the tip of an iceberg? Br Med J (Clin Res Ed) (1982) 1.91
A novel micro-assay for insulin autoantibodies. J Autoimmun (1997) 1.90
The Continuous Glucose Monitoring System (CGMS) in type 1 diabetic children is the way to reduce hypoglycemic risk. Diabetes Metab Res Rev (2002) 1.85
Organ-specific autoimmunity: a 1986 overview. Immunol Rev (1986) 1.84
Standardization of IVGTT to predict IDDM. Diabetes Care (1992) 1.83
Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives. Diabetes (1994) 1.82
Age-related islet autoantibody incidence in offspring of patients with type 1 diabetes. Diabetologia (2012) 1.81
Relative predispositional effects of HLA class II DRB1-DQB1 haplotypes and genotypes on type 1 diabetes: a meta-analysis. Tissue Antigens (2007) 1.77
Predicting insulin-dependent diabetes. Lancet (1988) 1.75
Autoantibodies to glutamic acid decarboxylase in palatal myoclonus and epilepsy. Ann Neurol (1994) 1.72
Cardiovascular safety of sulfonylureas: a meta-analysis of randomized clinical trials. Diabetes Obes Metab (2013) 1.71
Comparison of tissue transglutaminase-specific antibody assays with established antibody measurements for coeliac disease. J Autoimmun (1999) 1.70
Capillary whole blood measurement of islet autoantibodies. Diabetes Care (1999) 1.66
Evidence for an association between rheumatoid arthritis and autoimmune endocrine disease. Ann Rheum Dis (1983) 1.64
Islet isolation for allotransplantation: variables associated with successful islet yield and graft function. Diabetologia (2005) 1.62
Beta cell function during rapamycin monotherapy in long-term type 1 diabetes. Diabetologia (2010) 1.60
Relationship of the 37,000- and 40,000-M(r) tryptic fragments of islet antigens in insulin-dependent diabetes to the protein tyrosine phosphatase-like molecule IA-2 (ICA512). J Clin Invest (1995) 1.60
Minimal incidence of neonatal/infancy onset diabetes in Italy is 1:90,000 live births. Acta Diabetol (2011) 1.59
From the fetal liver to spleen and gut: the highway to natural antibody. Mucosal Immunol (2009) 1.59
Subclinical coeliac disease in schoolchildren from northern Sardinia. Lancet (1999) 1.58
Diabetes Antibody Standardization Program: evaluation of assays for insulin autoantibodies. Diabetologia (2010) 1.57
Antibodies to tissue transglutaminase C in type I diabetes. Diabetologia (1999) 1.57
Protracted diarrhoea of infancy: evidence in support of an autoimmune variant. Br Med J (Clin Res Ed) (1986) 1.55
Evidence for a primary autoimmune type of diabetes mellitus. Br Med J (1978) 1.55
Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes. Lancet (1990) 1.54
Size dependence during the development of the amphibian foot. Colchicine-induced digital loss and reduction. J Embryol Exp Morphol (1983) 1.53
Identification of protein tyrosine phosphatase-like IA2 (islet cell antigen 512) as the insulin-dependent diabetes-related 37/40K autoantigen and a target of islet-cell antibodies. J Immunol (1995) 1.53
Growth changes in children and adolescents with short-term diabetes. Diabetes Care (1998) 1.52
Cancer incidence and mortality in patients with insulin-treated diabetes: a UK cohort study. Br J Cancer (2005) 1.52